Skip to content
Open access

Association between iron status biomarkers and metabolic-endocrine parameters including insulin resistance, thyroid-stimulating hormone, and vitamin D3 in young women.

Sep 2026 · Biomeditsinskaia khimiia · Vol 72 4, pp. 296-302 · 0 citations · 20 references
Medicine

TL;DR

Iron status, particularly ferritin, plays a central role in metabolic dysregulation and may act as a biological mediator in insulin resistance and vitamin D metabolism, and potential pathways for targeted intervention are suggested.

Abstract

Iron metabolism has emerged as a potential regulator of metabolic and endocrine pathways, particularly in female health disorders. However, its role as a biological mediator linking insulin resistance, thyroid function, and vitamin D status remains insufficiently explored. The study aimed to analyze the role of iron status as a biological mediator in the pathogenesis of metabolic and hormonal disturbances, with a focus on insulin resistance, thyroid stimulating hormone (TSH), and vitamin D3. A cross-sectional study was conducted on 88 young, non-pregnant, fasting women aged 18-30 years with untreated iron deficiency. Iron status parameters (ferritin, serum iron, total iron-binding capacity (TIBC), and transferrin saturation) were evaluated alongside metabolic markers (insulin, glucose, HOMA-IR, QUICKI), as well as TSH, and vitamin D3 levels. Statistical analyses included multiple linear regression, binary logistic regression, and partial correlation controlling for age using SPSS version 28. The multiple linear regression model demonstrated a strong fit (R2 = 0.864, p < 0.001), with ferritin identified as an important independent Insulin Resistance Index (HOMA-IR) (β = -0.224, p < 0.001). Furthermore, ferritin showed a strong positive correlation with QUICKI (r = +0.76), indicating improved insulin sensitivity. Partial correlation analysis confirmed a strong independent association between ferritin and HOMA-IR (r = -0.803, p < 0.001), in addition to vitamin D3 (r = 0.781, p < 0.001). No significant relationship was observed between iron profile and TSH (p > 0.05). Logistic regression achieved perfect classification but was unstable due to complete separation. Iron status, particularly ferritin, plays a central role in metabolic dysregulation and may act as a biological mediator in insulin resistance and vitamin D metabolism. These findings highlight the importance of iron homeostasis in female health disorders and suggest potential pathways for targeted intervention.

Read PDF

Similar papers

Review Open access Oct 2026

Associations of Subclinical Hypothyroidism and Thyroid Autoimmunity with Insulin Resistance Independent of Adiposity: An Analysis of NHANES

A thyroid–inflammation–insulin pathway has been proposed in which thyroid dysfunction promotes inflammation and thereby reduces insulin sensitivity, but adiposity-adjusted population evidence is limited. This cross-sectional analysis examined whether subclinical hypothyroidism (SCH) and thyroid autoimmunity are associa...

Iman Taher Hussein · 0 citations
Open access Sep 2026

Serum FGF21 and GDF15 as Indicators of Mitochondrial Stress and Their Association with Insulin Resistance and Oxidative Stress a Comparative Study in Adults Diagnosed with Metabolic Syndrome

Background: Metabolic syndrome is characterized by central adiposity, dyslipidemia, elevated blood pressure, and impaired glucose regulation, and is strongly linked to insulin resistance, oxidative stress, and mitochondrial perturbation. Fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) a...

Ibrahim Khalaf Hameed · 0 citations
Open access Sep 2026

Vitamin (B1, B6, B12, D, and Folate) and Mineral (Iron, Selenium, and Magnesium) Status Across the Spectrum of Severe Obesity: An Integrative Multivariate Analysis of Metabolic and Nutritional Profiles

Background: Obesity is frequently accompanied by metabolic dysfunction and micronutrient deficiencies, yet data on individuals with severe obesity (BMI ≥ 50 kg/m2) remain limited. Understanding how vitamin and mineral status changes across the adiposity continuum may optimize personalized nutritional management in seve...

Hannah Sabados, Sandra Möwius, Ute M. Stern et al. · 0 citations
Open access Sep 2026

Do growth hormone and insulin-like growth factor-1 reflect metabolic disturbances in acromegaly? A retrospective cohort study

Aims: To investigate the relationships between serum growth hormone (GH) and insulin-like growth factor-1 (IGF-1) concentrations and metabolic parameters, including glucose metabolism and lipid profile, in patients with acromegaly.Methods: This retrospective observational study included 74 patients with acromegaly foll...

Sadettin Öztürk, Esma Gülsün Arslan Cellat, Burak Erbağcı et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.